Trial
NCT02665221
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
Multiple Sclerosis
Intervention
No Treatment Arm
Why stopped
It was decided on 9/21/2016 to terminate this study early because LogPad devices the patients used to record their injection data was flawed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-18